Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in Syrian hamsters

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2585-2592

  Hardardóttir, Ingibjörg ^a,b   Moser, Arthur H ^a,b   Fuller, John ^a,b   Fielding, Christopher ^c   Feingold, Kenneth ^a,b   Grünfeld, Carl ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute phase reaction; cholesteryl ester transfer protein; corticosteroid; immunologic factors; lipopolysaccharide

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOKINE; DEXAMETHASONE; ENDOTOXIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; RECOMBINANT INTERLEUKIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ACUTE PHASE RESPONSE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; HEART; IMMUNOBLOTTING; INFECTION; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; TISSUE REPAIR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029888970     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118707     Document Type: Article

References (52)

1. Mackiewicz, A., I. Kushner, and H. Baumann, editors. 1993. Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications. CRC Press. Boca Raton, FL.
2. Hardardóttir, I., C. Grünfeld, and K.R. Feingold. 1994. Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5:207-215.
3. Memon, R.A., C. Grunfeld, A.H. Moser, and K.R Feingold. 1993. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 132:2246-2253.
4. Feingold, K.R., I. Hardardóttir, R. Memon, E.J.T. Krul, A.H. Moser, J.M. Taylor, and C. Grunfeld. 1993. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J. Lipid Res. 34: 2147-2158.
5. Hoffman, J.S., and E.P. Benditt. 1983. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. J. Clin. Invest. 71:926-934.
6. Kisilevsky, R., and L. Subrahmanyan. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab. Invest. 66:778-785.
7. Kawakami, M., T. Murase, H. Itakura, N. Yamada, N. Ohsawa, and F. Takaku. 1986. Lipid metabolism in endotoxic rats: decrease in hepatic triglyceride lipase activity. Microbiol. Immunol. 30:849-854.
8. Magilavy, D.B., R. Zhan, and DD. Black. 1993. Modulation of murine hepatic lipase activity by exogenous and endogenous Kupffer-cell activation. Biochem. J. 292:249-252.
9. Meraïhi, Z., O. Lutz, J.-M. Scheftel, A. Frey, J. Ferezou, and A.C. Bach. 1991. Decreased lypolytic activity in tissues during infectious and inflammatory stress. Nutrition. 7:93-97.
10. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkilä, and M.-R. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37:859-865.
11. Barrans, A., X. Collet, R. Barbaras, B. Jaspard, J. Manent, C. Vieu, H. Chap, and B. Perret. 1994. Hepatic lipase induces the formation of pre-α1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. J. Biol. Chem. 269: 11572-11577.
12. Castro, G.R., and C.J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27:25-29.
13. Francone, O.L., A. Gurakar, and C. Fielding. 1989. Distribution and functions of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproleins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J. Biol. Chem. 264:7066-7072.
14. Ettinger, W.H., L.D. Miller, J.J. Albers, T.K. Smith, and J.S. Parks. 1990. Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin:cholesterol acyltransferase in cynomolgus monkeys. J. Lipid Res. 31:1099-1107.
15. Auerbach, B.J., and J.S. Parks. 1989. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin:cholesterol acyltransferase and lipase deficiency. J. Biol. Chem. 264:10264-10270.
16. Ly, H., O.L. Francone, C.J. Fielding, J.K. Shigenaga, A.H. Moser, C. Grunfeld, and K.R. Feingold. 1995. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res. 36:1254-1263.
17. Tall, A.R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34:1255-1274.
18. Fielding, C.J. 1993. Lipid transfer proteins: catalysts, transmembrane carriers and signalling intermediates for intracellular and extracellular lipid reactions. Curr. Opin. Lipidol. 4:218-222.
19. Masucci-Magoulas, L., P. Moulin, X.C. Jiang, H. Richardson, A. Walsh, J.L. Breslow, and A. Tall. 1995. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein after lipopolysaccharide administration in human CETP transgenic mice. J. Clin. Invest. 95:1587-1594.
20. Quinet, E.M., P. Huerta, D. Nancoo, A.R. Tall, Y.L. Marcel, and R. McPherson. 1993. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. J. Lipid Res. 34:845-852.
21. Quig, D.W., C.M. Arbeeny, and D.B. Zilversmit. 1991. Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma. Biochim. Biophys. Acta. 1083:257-264.
22. Au-Young, J., and C.J. Fielding. 1992. Synthesis and secretion of wild-type and mutant human plasma cholesteryl ester transfer protein in baculovirus-transfected insect cells: The carboxyl-terminal region is required for both lipoprotein binding and catalysis of transfer. Proc. Natl. Acad. Sci. USA. 89: 4094-4098.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
24. Morrow, J.F., R.S. Steraman, C.G. Peltzman, and D.A. Potter. 1981. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc. Natl. Acad. Sci. USA. 78:4718-4722.
25. Clarke, C.F., P.A. Edwards, S.-F. Lan, R.D. Tanaka, and A.M. Fogelman. 1983. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels in rat liver. Proc. Natl. Acad. Sci. USA. 80:3305-3308.
26. Jiang, X.C., P. Moulin, E. Quinet, I.J. Goldberg, L.K. Yacoub, L.B. Agellon, D. Compton, R. Schnitzer-Polokoff, and A. Tall. 1991. Mammalian adipose tissue and muscle are major sources of lipid transfer protein in mRNA. J. Biol. Chem. 266:4631-4639.
27. Baumann, H., C. Richards, and J. Gauldie. 1987. Interaction among hepatocyte-stimulating factors, interleukin-1 and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J. Immunol. 139:4122-4128.
28. Hardardóttir, I., A.H. Moser, R. Memon, C. Grünfeld, and F.R. Feingold. 1994. Effects of TNF, IL-1, and the combination of both cytokines on cholesterol metabolism in Syrian hamsters. Lymphokine Cytokine Res. 13:161-166.
29. Hardardóttir, I., S.T. Kunitake, A.H. Moser, W.T. Doerrler, J.H. Rapp, C. Grünfeld, and K.R. Feingold. 1994. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (Clusterin) in Syrian hamsters. J. Clin. Invest. 94:1304-1309.
30. Feingold, K.R., I. Staprans, R.A. Memon, A.M. Moser, J.K. Shigenaga, W. Doerrler, C.A. Dinarello, and C. Grunfeld. 1992. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33:1765-1776.
31. Goldberg, I.J., W.S. Blaner, T.M. Vanni, M. Moukides, and R. Ramakrishnan. 1990. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J. Clin. Invest. 86:463-473.
32. Albrink, M.J., R.M. Krauss, F.T. Lindgren, and V.D. Groeben. 1980. Inter correlations among high density lipoprotein, obesity and triglycerides in a normal population. Lipids. 15:668-678.
33. Schaefer, E.J., R.I. Levy, D.W. Anderson, R.N. Danner, J.H.B. Brewer, and W.C. Blackwelder. 1978. Plasma-triglycerides in regulation of H.D.L.-cholesterol levels. Lancet. ii:391-392.
34. Iglesias, A., J.A. Contreras, M. Marínes-Pardo, A. Entrala, E. Herrera, and M.A. Lasunción. 1993. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias. Clin. Chim. Acta. 221: 73-89.
35. Yamashita, S., Y. Matsuzawa, M. Okazaki, H. Kato, T. Yasugi, H. Akioka, K. Hirano, and S. Tarui. 1988. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 70:7-12.
36. Brown, M.L., A. Inazu, C.B. Hesler, L.B. Agellon, C. Mann, M.E. Whitlock, Y.L. Marcel, R.W. Milne, J. Koizumi, H. Mabuchi, R. Takeda, and A.R. Tall. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature (Lond.). 342:448-451.
37. Agellon, L.B., A. Walsh, T. Hayek, P. Moulin, X.C. Jiang, S.A. Shelanski, J.L. Breslow, and A.R. Tall. 1991. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266:10796-10801.
38. Hayek, T., T. Chajek-Shaul, A. Walsh, L.B. Agellon, P. Moulin, A.R. Tall, and J.L. Breslow. 1992. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J. Clin. Invest. 90:505-510.
39. Nonogaki, K., A.H. Moser, K.R. Feingold, and C. Grunfeld. 1994. α-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats. Endocrinology. 135:2644-2650.
40. Okusawa, S., J.A. Gelfand, T. Ikejima, R.J. Connolly, and C.A. Dinarello. 1988. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81:1162-1172.
41. Levine, D.M., T.S. Parker, T.M. Donnelly, A. Walsh, and A.L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90:12040-12044.
42. Parker, T.S., D.M. Levine, J.C. Chang, J. Laxer, C.C. Coffin, and A.L. Rubin. 1995. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63:253-258.
43. Harris, H.W., C. Grunfeld, K.R. Feingold, and J.H. Rapp. 1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86:696-702.
44. Steinbrecher, U.P., J.L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Arteriosclerosis. 7:135-143.
45. Parthasarathy, S., J. Barnett, and L.G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044:275-283.
46. Spolarics, Z., P.H. Pekala, G.J. Bagby, and J.J. Spitzer. 1993. Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochem. Biophys. Res. Commun. 193:1211-1215.
47. Spolarics, Z., and J.J. Spitzer. 1995. Acute endotoxin tolerance is accompanied by stimulated glucose use in macrophage rich tissues. Biochem. Biophys. Res. Commun. 211:340-346.
48. Orlinska, U., and R.C. Newton. 1993. Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes. J. Cell. Physiol. 157:201-208.
49. Zamir, O., P.O. Hasselgren, D.V. Allmen, and J.E. Fishcer. 1993. The effect of interleukin-1α and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle. J. Surg. Res. 50: 579-583.
50. Zamir, O., P.O. Hasselgren, D. Allmen, and J.E. Fischer. 1993. In vivo administration of interleukin-1α induces muscle proteolysis in normal and adrenalectomized rats. Metabolism. 42:204-208.
51. Zamir, O., P.O. Hasselgren, S.L. Kunkel., J. Frederick, T. Higashiguchi, and J.E. Fischer. 1992. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127:170-174.
52. Hall-Angeras, M., U. Angeras, O. Zamir, P.O. Hasselgren, and J.E. Fischer. 1990. Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery. 108:460-466.